Geode Capital Management’s Relmada Therapeutics RLMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $182K | Buy |
302,354
+471
| +0.2% | +$283 | ﹤0.01% | 3905 |
|
|
2025
Q1 | $81.5K | Sell |
301,883
-955
| -0.3% | -$258 | ﹤0.01% | 4086 |
|
|
2024
Q4 | $158K | Sell |
302,838
-1,664
| -0.5% | -$866 | ﹤0.01% | 3969 |
|
|
2024
Q3 | $987K | Buy |
304,502
+44,004
| +17% | +$143K | ﹤0.01% | 3359 |
|
|
2024
Q2 | $782K | Buy |
260,498
+4,411
| +2% | +$13.2K | ﹤0.01% | 3401 |
|
|
2024
Q1 | $1.19M | Buy |
256,087
+12,674
| +5% | +$58.9K | ﹤0.01% | 3300 |
|
|
2023
Q4 | $1.01M | Buy |
243,413
+3,509
| +1% | +$14.5K | ﹤0.01% | 3354 |
|
|
2023
Q3 | $720K | Buy |
239,904
+5,542
| +2% | +$16.6K | ﹤0.01% | 3458 |
|
|
2023
Q2 | $577K | Sell |
234,362
-267,981
| -53% | -$659K | ﹤0.01% | 3588 |
|
|
2023
Q1 | $1.14M | Buy |
502,343
+16,092
| +3% | +$36.4K | ﹤0.01% | 3287 |
|
|
2022
Q4 | $1.7M | Sell |
486,251
-4,561
| -0.9% | -$15.9K | ﹤0.01% | 3113 |
|
|
2022
Q3 | $18.2M | Sell |
490,812
-6,515
| -1% | -$241K | ﹤0.01% | 1807 |
|
|
2022
Q2 | $9.44M | Buy |
497,327
+42,423
| +9% | +$806K | ﹤0.01% | 2292 |
|
|
2022
Q1 | $12.3M | Buy |
454,904
+110,947
| +32% | +$2.99M | ﹤0.01% | 2210 |
|
|
2021
Q4 | $7.75M | Buy |
343,957
+90,254
| +36% | +$2.03M | ﹤0.01% | 2625 |
|
|
2021
Q3 | $6.65M | Buy |
253,703
+9,371
| +4% | +$246K | ﹤0.01% | 2744 |
|
|
2021
Q2 | $7.82M | Buy |
244,332
+5,060
| +2% | +$162K | ﹤0.01% | 2633 |
|
|
2021
Q1 | $8.42M | Buy |
239,272
+33,585
| +16% | +$1.18M | ﹤0.01% | 2470 |
|
|
2020
Q4 | $6.6M | Buy |
205,687
+5,437
| +3% | +$174K | ﹤0.01% | 2435 |
|
|
2020
Q3 | $7.53M | Buy |
200,250
+2,007
| +1% | +$75.5K | ﹤0.01% | 2139 |
|
|
2020
Q2 | $8.87M | Buy |
198,243
+90,554
| +84% | +$4.05M | ﹤0.01% | 1990 |
|
|
2020
Q1 | $3.67M | Buy |
107,689
+10,581
| +11% | +$361K | ﹤0.01% | 2321 |
|
|
2019
Q4 | $3.79M | Buy |
+97,108
| New | +$3.79M | ﹤0.01% | 2615 |
|